|
Cipher Pharmaceuticals announces U.S. commercial entry through acquisition of …
Insurance News Net In connection with the offering, Cipher has issued Athyrium 600,000 common share purchase warrants. The warrants are exercisable at US$9.22 (equal to the five-day volume-weighted average price on the Toronto Stock Exchange prior to closing converted … |
